caesarean scar niche/isthmocele and fibroids Flashcards

1
Q

Definition (international Niche Taskforce) and incidence

A

An indentation at the site of the caesarean scar with a depth of at least 2mm and visible by means of a TVUSS.

Prev definition used 1mm.
It is a myometrial defect that forms because of imperfect healing.
~50-60% of women with a history of a caesarean section will have a niche.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Associated symptoms

A

Asymptomatic
Postmenstrual spotting.
Prolonged menses.
dysmenorrhoea and chronic pelvic pain.
Vaginal discharge.
May also cause secondary infertility.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Theoretical impact on fertility

A

Accumulation of blood, mucus and fluid in the niche
Impaired myometrial contractility

Can lead to:
Impaired sperm migration and viability
Hostile uterine environment for implantation
Change the microbiome/cause chronic endometritis or inflammation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Evidence of impact on secondary infertility.

A

CS reduced probability of a subsequent pregnancy by 10% relative to a vaginal birth but none looked specifically at uterine niche.

Retrospective study showed women undergoing their first IVF cycle reported significantly lower live birth rates in those with a previous CS cf a previous vaginal birth.

Retrospective study meta-analysis in F&S November 2023 -
P - Women undergoing IVF cycle
I - Isthmocele
C - Those with a CS without isthmocele and those with a vaginal birth
O - Isthmocele associated with a lower live birth rate than both women with a previous CS without isthmocele and those with a vaginal birth
Results more significant for those who have intra-cavity fluid, if no ICF seen then results were similar to that of no isthmocele

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Risks associated

A

Obstetric:
Casearean scar ectopic
Placenta praevia, accreta, increta and percreta
Scar dehiscence
Uterine rupture
*secondary infertility

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Options for management

A

Nil/conservative
Medical management - mentrual suppression
Surgical repair -
- Hysteroscopic
- Laparoscopic
- Vaginal
- Laparotomy
Hysterectomy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Risk factors for developing a CSD

A

increasing number of CS
Longer duration of labour
Dilatation beyond 5 cm
Peripartum infection
Increased BMI
Low versus high hysterotomy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Fibroids - indication for myomectomy in infertile women (RANZCOG guideline)

A

Fibroid size, number and location within the uterus may impact on the utility of myomectomy, and this will need to be considered in the management plan for an individual patient.
The indications for myomectomy in infertile women may be summarized as follows:
* Infertile women and those women undergoing ART who have a demonstrated SM fibroid(s).
* Infertile women with symptomatic fibroid(s), such as heavy vaginal bleeding or pressure symptoms, even though trial evidence does not show clear fertility benefit, the presence of symptoms may justify the intervention.
* Couples presenting with multiple failed cycles ART where the female partner has IM fibroids.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Treatment that should only be done in a research setting

A
  1. Uterine artery ligation (temporary or permanent)
  2. Uterine artery embolisation
  3. Magentic resonance guided focused ultrasound surgery (MRgFUS)
  4. Myolysis - application of an energy source directed at the fibroids intending to stop blood flow and cause necrosis whilst not damaging the surrounding tissues (laser myolysis or cryomyolysis are examples)
  5. Radio-frequency ablation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Medical management of fibroids in the context of research setting

A

Delays efforts to conceive and not recommended.
Can be considered for:
Short term use of GnRH analogue considered for preoperative correction of anaemia or short term reduction in fibroid volume.
Ulipristil acetate is not recommended due to the risk of significant adverse effects (liver failure)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

FIGO classification system for AUB in reproductive years

A

PALM COEIN

Polyp
Adenomyosis
Leiomyomoa (submucous and other)
Malignancy and hyperplasia

Coagulopathy
Ovulatory dyfunction
Endometrial
Iatrogenic
Not otherwise classified

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

FIGO classification for leiomyoma

A

Combination of TVUS and TA USS to identify leiomyomas
Subclassification requires determination of relationship of the endometrium with the leiomyoma (contact or not) - done with TVUS, contrast sonohysterography, hysteroscopy or MRI.
Tertiary subclassification requires the clinican to clarify the relationship of the leiomyomas with the endometrium, endometrial cavity, myometrium and uterine serosa.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Proposed MoA for fibroids affecting fertility.

A

Thicker capsule - A capsule that surrounds the fibroid can be considered a separate entity. This pseudocapsule consists of compressed
myometrium and contains nerves. An increasein pseudocapsule
thickness may increase the number of neuroendocrine fibers,
influencing muscle contractility and uterine peristalsis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Cochrane review 2017 GnRHa pretreatment prior to surgery for uterine fibroids

A

GnRHa resulted in:
reduction in uterine and fibroid volumes.
Increase in preoperative Hb
Resulted in higher rate of adverse events (hot flushes etc)

Hysterectomy - reduced operative time, less operative blood loss, fewer blood transfusions, fewer postoperative complications.

Myomectomy - reduced intraoperative blood loss

Note: Whether pretreatment prior to IVF for intramural fibroids improves LBR has not be studied.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Cochrane 2020 Surgical treatment of fibroids for subfertility.

A

four RCTs with 442 participants.
Very low-quality with the main limitations being due to serious imprecision, inconsistency and indirectness.
There is limited evidence to determine the role of myomectomy for infertility in women with fibroids as only one trial compared myomectomy with no myomectomy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Risk factors for fibroids

A

Increasing incidence with age
Black women > white women
Family history of fibroids x3 RR

17
Q

Fibroid pathology

A

Monoclonal tumours predominantly composed of smooth muscle cells with variable amounts of connective tissues.
Can undergo atrophy, internal haemorrhage, fibrosis or calcification. Can also undergo degeneration.

18
Q

Radiographic features of fibroids

A

Ultrasound:
Well defined, solid, concentric, hypoechoic mass with variable amount of acoustic shadowing.
Hypoechoic (can be iso or hyperechoic)
Discrete lesion/lesions
Can see calcification (echogenic focus), cystic areas of necrosis can also be seen.
Venetian blind artifact may be seen but edge shadowing +/- sense posterior shadowing can also b seen.

19
Q

Causes of fibroid growth

A

Benign tumours – monoclonal (single cell) with expansion of surrounding extra-cellular matrix under influence of ovarian hormones.

  1. Hormonally dependent
    o Increased ERa receptors – allow permissive effect for P to act
    o Increased PR receptors – cause fibroid growth due to paracrine effects
    o Anti-progestins or AI’s stop fibroid growth, E alone not enough to stimulate fibroid growth
  2. Cytokine & Growth factors
    o b-catenin and TGF-b pathways alter stem cell differentiation
  3. Genetics
    o Fumurate hydratase deficiency: predisposes ♀ to multiple fibs
    o MED12 & HMGA2 mutations – transforms myometrial stem cells to fibroid stem cell
  4. Epigenetic effects
    o DNA methylation
    o Histone modification
    o miRNA alterations
20
Q
A